What Happens During a Regenerative Medicine Consultation?

Patients who contact a regenerative medicine clinic often arrive with a clear goal: they want treatment. They have researched their options, they believe stem cell therapy or PRP may help their condition, and they are ready to move forward. The consultation can feel like an obstacle between them and the procedure they have already decided they want.

That mindset, while understandable, inverts the actual purpose of the consultation. The consultation is not a formality before treatment. It is the most consequential clinical event in the entire process. Every decision that follows – whether to proceed, which treatment to use, how many procedures to plan, and what outcomes to realistically expect – flows directly from what happens during this first appointment. Patients who understand what the consultation covers and why each element matters tend to have better experiences and better-calibrated expectations throughout their care.

Why the Consultation Is the Most Important Step

What Gets Decided Before Any Treatment Begins

A regenerative medicine consultation is a clinical decision-making event, not a sales conversation. By the time the appointment ends, a physician should have enough information to answer several critical questions. Is this patient a reasonable candidate for regenerative therapy? Which specific treatment, or combination of treatments, aligns with the clinical findings and patient goals? What does an honest timeline and outcome range look like for this individual? What additional information, such as imaging or laboratory results, is needed before proceeding?

These questions cannot be answered without a thorough evaluation. A physician who recommends a specific treatment before reviewing your medical history, examining the affected area, and discussing your goals in detail has not done this work. When a consultation is rushed, incomplete, or skipped in favor of moving directly to a procedure booking, the downstream consequences are predictable: patients who are not good candidates receive treatment they are unlikely to benefit from, expectations are misaligned, and when results disappoint, only the patient is surprised.

The consultation also establishes the clinical baseline. This baseline matters not just for planning the initial procedure but for evaluating the response over time. Tracking progress requires knowing where the patient started. Without a documented baseline of pain scores, functional limitations, and imaging findings, the physician has no reference point for evaluating whether a patient improved, stayed the same, or declined after treatment.

How a Thorough Consultation Protects the Patient

One of the most important functions of a well-conducted consultation is identifying patients who are not candidates. This is a protective function, not a rejection. A patient with active infection near the treatment site cannot safely receive an injection into that area. A patient on anticoagulant therapy requires careful planning before any invasive procedure. A patient with end-stage joint degeneration, where the structural integrity needed to support biological repair is no longer present, may be better served by surgical evaluation than by a regenerative procedure that cannot address the underlying anatomy.

Honest candidacy assessment serves the patient’s interests even when it means directing them toward a different path. A physician who tells a patient that regenerative therapy is not appropriate for their condition, or that surgery should come first, provides genuine value. A clinic that treats every patient regardless of findings does not.

The consultation also creates the foundation for informed consent. The patient who understands what the treatment involves, what the realistic range of outcomes looks like, what the recovery process requires, and what happens if the treatment does not produce the expected response is in a position to make a genuine decision. Informed consent is not a signature on a form. It is a condition of understanding that the consultation is designed to create.

What the Consultation Covers

Medical History Review

The physician begins by understanding the patient’s full medical context, with particular attention to information that affects candidacy and treatment planning. This means reviewing prior treatments for the presenting condition, including physical therapy, medications, previous injections, and surgeries. A patient who has already received three cortisone injections into the same joint has important information in that history. Repeated corticosteroid exposure has been associated in the literature with potential cartilage effects, and that history may influence timing and approach.

Comorbidities receive careful attention because some medical conditions affect whether a patient can safely undergo a procedure or whether they are likely to respond. Active infection anywhere in the body is generally a contraindication to elective injections. Autoimmune conditions may affect how the patient’s biological material performs. Diabetes affects healing biology and may alter expected timelines. A patient taking anticoagulants requires a specific protocol around procedure timing.

Current medications are reviewed in detail. Some medications suppress platelet function and affect PRP yield. Others affect the inflammatory response that regenerative therapies rely on. The physician needs this information to counsel the patient appropriately and may request that certain medications be paused for a specified period before the procedure, in coordination with the prescribing provider.

Prior regenerative treatments and their outcomes are particularly valuable. A patient who received PRP elsewhere six months ago and reported no change provides useful clinical information. That history may suggest that a more concentrated or cell-based approach is appropriate, or it may raise questions about diagnosis or delivery accuracy that should be explored before proceeding.

Symptom and Condition Assessment

The physician conducts a detailed review of the patient’s current symptoms, focusing on the specific location of pain or dysfunction, how the symptoms present, and how they affect daily function. Pain that is constant differs from pain that occurs only with specific movements. Pain that limits sleep is clinically different from pain that is present but manageable. These distinctions help characterize the severity and nature of the condition and guide the treatment discussion.

Duration of symptoms is an important variable. Acute injuries and chronic degenerative conditions may both be appropriate candidates for regenerative therapy, but the biology and expected timelines differ. The trajectory of the condition matters as well. A patient whose symptoms have been gradually worsening over two years presents a different picture than one who had a sudden injury and is now in a subacute recovery phase.

The physician asks what makes symptoms better or worse. Activity modification, rest, position, heat, ice, and prior injections all provide information about the mechanism driving the pain. A condition that relieves completely with rest but is immediately provoked by loading is different from one that is constant regardless of activity.

Prior imaging findings are reviewed if the patient brings them. Understanding what has already been documented on MRI or X-ray provides a structural picture of the condition that the clinical examination supplements.

Imaging Review and Diagnostic Discussion

Imaging is not always required before a first consultation, but it is almost always required before a first procedure. The physician will review any existing imaging and determine whether additional studies are needed before treatment can be planned.

For joint conditions, X-rays provide information about the degree of joint space narrowing and bony changes. This information is used to grade the severity of osteoarthritis using standardized scales. The Kellgren-Lawrence grading system, for example, classifies knee osteoarthritis from grade 1 (minor osteophytes) to grade 4 (marked joint space loss with bone-on-bone contact). This grading is clinically relevant because it directly affects candidacy for regenerative therapy. Patients with grade 2 or 3 changes have sufficient remaining joint structure to support a biological repair environment. Grade 4 changes may indicate that structural integrity has been lost to a degree that limits what regenerative therapy can accomplish.

MRI provides detailed information about soft tissue integrity. For tendon conditions, MRI shows the degree of tendon degeneration, partial tears, or complete tears. For joint conditions, MRI characterizes cartilage thickness, meniscal status, and ligamentous integrity. This information is often more directly relevant to regenerative candidacy than X-ray findings alone.

When a patient does not have recent imaging, the physician may order appropriate studies before proceeding. The cost of the imaging is worth the diagnostic clarity it provides. Treating a condition without knowing its structural status is like navigating without a map.

Goal Setting and Expectation Calibration

Perhaps the most practically important part of the consultation is the conversation about what the patient hopes to achieve and what is realistically achievable. This conversation needs to happen honestly, even when the honest version of it is uncomfortable.

Patients come to regenerative medicine consultations with a wide range of goals. Some want to reduce pain enough to return to activities they have had to give up. Some want to avoid joint replacement surgery. Some want to reduce their reliance on pain medication. Some have a specific athletic goal, such as returning to running or resuming recreational sports. Some simply want to feel better in daily function.

These goals are legitimate and the physician should take them seriously. But the physician also carries a responsibility to tell the patient what is and is not realistic for their specific condition, based on the actual clinical and imaging findings. A patient with grade 3 knee osteoarthritis who wants to return to competitive distance running needs to hear an honest assessment of what regenerative therapy may or may not produce, not an optimistic projection designed to close the consultation on a positive note.

Realistic timelines should be discussed at this stage. Most patients who respond to regenerative therapy begin noticing changes between six and twelve weeks after their procedure, with continued evolution of the response over months. The physician who sets this expectation at the consultation gives the patient a frame of reference for interpreting their own experience during recovery.

How a Care Plan Is Developed

Why Individualized Plans Differ from Standard Protocols

No two patients with knee pain have identical clinical presentations, and no single treatment protocol applies equally across all of them. The care plan that emerges from a regenerative medicine consultation at a physician-led regenerative clinic reflects the specific combination of factors present in that patient: the type and severity of the condition, the patient’s overall health, the goals expressed during the consultation, prior treatment history, and the cell yield produced by the in-house laboratory during the procedure.

This last point is worth highlighting. A physician-led regenerative clinic that processes stem cell material in its own laboratory means that laboratory results, including cell concentration and viability, are available before injection. This allows the physician to incorporate actual cell yield into final treatment planning rather than proceeding based on estimated yield. If a patient’s cell yield is lower than expected, the physician can discuss adjustments, including concentration adjustments or treatment sequencing, in real time.

Standardized protocols in regenerative medicine represent averages applied to populations. They are useful starting points but they are not care plans. The consultation is the event at which a starting point becomes an individualized plan.

What the Plan Typically Includes and Why

A complete care plan addresses several elements beyond the name of the treatment. The physician specifies which therapy or combination of therapies is recommended and explains the rationale. For some patients, PRP is appropriate as a primary treatment for a tendon condition. For others, bone marrow aspirate concentrate represents the appropriate level of intervention given the severity of the joint condition. For still others, a combination approach, such as A2M therapy to address the protease environment in a degenerating joint, followed by stem cell delivery, may be discussed.

The number of procedures in the initial plan is specified, along with the rationale for that number. Some conditions are addressed with a single procedure. Others may benefit from a series of treatments, particularly if the condition is complex or bilateral.

Post-procedure protocols are outlined, including activity restrictions, medications to avoid during the recovery window, and when physical therapy or other adjunct treatments are introduced. Patients who understand why they are being asked to avoid NSAIDs during the recovery period are more likely to comply than patients who receive instructions without context.

Follow-up scheduling is discussed so patients know when they will be evaluated and what will be assessed at each visit. The plan may be adjusted based on the patient’s response after the first procedure. The consultation establishes the initial plan, but the physician treats the plan as a living document that evolves with clinical feedback.

What Patients Should Bring and Ask

What to Bring: Records, Imaging, and Prior Treatment History

Patients who arrive prepared allow the consultation to focus on clinical discussion rather than information gathering. Bringing recent imaging, ideally within the past twelve months, gives the physician immediate access to the structural picture of the condition. X-ray and MRI images on disc or through an imaging portal are ideal, though written reports are also useful.

Prior injection records, physical therapy discharge summaries, and notes from other treating providers all help the physician understand what has already been tried, what the patient’s response has been, and what conclusions other clinicians have drawn. A current medication list, including supplements and over-the-counter medications, should be prepared in advance. Surgical history related to the affected area, including dates and procedures, is relevant.

If a patient does not have recent imaging, the physician will address this at the consultation and, in many cases, imaging can be ordered as part of the pre-procedure workup. The absence of prior imaging does not prevent a productive consultation, but it does mean a procedure cannot typically be scheduled until imaging is reviewed.

The Five Questions Most Patients Forget to Ask at a First Consultation

Most patients arrive with the right general questions. They want to know whether they are a good candidate, what the procedure involves, and how long recovery takes. These are important. But clinical experience suggests there are five additional questions that often go unasked and that provide essential information.

First: where will my cells be processed, and can I receive the laboratory report before the procedure? In-house processing means the physician has direct oversight of preparation quality. Asking for the cell count and viability report before injection is reasonable and appropriate. A clinic that processes cells in-house should be able to provide this information.

Second: what imaging guidance will be used during delivery, and was that modality chosen specifically for my target structure? The answer should name a specific modality and provide a brief clinical rationale. “We use ultrasound for your type of injection because it allows real-time soft tissue visualization and confirms needle placement before any material is released” is an informative answer.

Third: what is your experience with my specific condition? Experience with knee osteoarthritis is not the same as experience with lumbar disc disease or rotator cuff tendinopathy. Asking about condition-specific experience gives you relevant information.

Fourth: under what conditions would you consider me a non-candidate? A physician who can articulate clear disqualifying criteria, such as active infection, grade 4 joint changes, or specific medication conflicts, demonstrates that candidacy evaluation is rigorous rather than assumed.

Fifth: what does follow-up look like, and how will we track my progress? The answer should describe a structured follow-up schedule with specific outcome measures, not a vague promise to “check in.” Understanding how progress will be measured helps patients know what to monitor and ensures the clinical team has the information needed to evaluate and adjust the plan.

These questions do not require technical knowledge to ask. They reflect the concerns of any informed patient, and the answers, or the absence of clear answers, tell you something important about the clinic you are evaluating.

Sources

Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. This content is not a substitute for consultation with a qualified, licensed healthcare provider. Regenerative medicine procedures vary in outcomes based on individual health status, condition severity, and other clinical factors. No specific results are guaranteed. Consult a board-certified physician to determine whether any treatment discussed here is appropriate for your situation.